Direkt zum Inhalt
Merck
  • Synthesis and anticonvulsant activity of trans- and cis-2-(2,6-dimethylphenoxy)-N-(2- or 4-hydroxycyclohexyl)acetamides and their amine analogs.

Synthesis and anticonvulsant activity of trans- and cis-2-(2,6-dimethylphenoxy)-N-(2- or 4-hydroxycyclohexyl)acetamides and their amine analogs.

Bioorganic & medicinal chemistry (2011-10-11)
Elżbieta Pękala, Anna M Waszkielewicz, Edward Szneler, Maria Walczak, Henryk Marona
ZUSAMMENFASSUNG

A group of trans- and cis-2-(2,6-dimethylphenoxy)-N-(2-hydroxycyclohexyl)acetamides (1-7) and -ethylamines (8-9) have been synthesized and investigated for their anticonvulsant activity. One of them, racemic trans-2-(2,6-dimethylphenoxy)-N-(2-hydroxycyclohexyl)acetamide proved to be the most effective in MES (mice, ip), exhibiting ED(50)=42.97 mg/kg b.w. and TD(50)=105.67 mg/kg b.w. It also proved protection in focal seizures (electric kindling, rats, ip) and it raises seizure threshold. The mechanism of action is inhibition of voltage-gated sodium currents and enhancement of GABA effect. Safety pharmacology assay on threshold tonic extension revealed no lowering of the seizure threshold.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Carbamazepin, powder
Sigma-Aldrich
5,5-Diphenylhydantoin, ≥98%
Sigma-Aldrich
2-Propylpentansäure
Sigma-Aldrich
Carbamazepin, meets USP testing specifications